These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 3929343)

  • 1. The need for pilot studies and surgery-only controls in adjuvant therapy trials for large-bowel cancer.
    Weber-Stadelmann W
    Recent Results Cancer Res; 1985; 98():126-9. PubMed ID: 3929343
    [No Abstract]   [Full Text] [Related]  

  • 2. Intraportal chemotherapy in colorectal carcinoma as an adjuvant modality.
    Metzger U; Mermillod B; Aeberhard P; Gloor F; Bissat A; Egeli R; Laffer U; Martinoli S; Mueller W; Schroeder R
    World J Surg; 1987 Aug; 11(4):452-8. PubMed ID: 3114965
    [No Abstract]   [Full Text] [Related]  

  • 3. Long-term results of single course of adjuvant intraportal chemotherapy for colorectal cancer. Swiss Group for Clinical Cancer Research (SAKK).
    Lancet; 1995 Feb; 345(8946):349-53. PubMed ID: 7845115
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hematological toxicity of adjuvant portal liver infusion with fluorouracil, mitomycin and heparin.
    Weber W; Metzger U; Laffer U; Egeli R
    Anticancer Res; 1991; 11(1):365-8. PubMed ID: 1902076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rationale and indications for perfusion in liver tumors: current data.
    Schwemmle K; Link KH; Rieck B
    World J Surg; 1987 Aug; 11(4):534-40. PubMed ID: 3114966
    [No Abstract]   [Full Text] [Related]  

  • 6. Phase II trial of 5-fluorouracil, adriamycin, and mitomycin C in advanced colorectal cancer.
    Haller DG; Woolley PV; Macdonald JS; Smith LF; Schein PS
    Cancer Treat Rep; 1978 Apr; 62(4):563-5. PubMed ID: 350394
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adjuvant therapy for colorectal cancer: the NSABP clinical trials.
    Wolmark N
    Adv Exp Med Biol; 1988; 244():261-6. PubMed ID: 3073660
    [No Abstract]   [Full Text] [Related]  

  • 8. Adjuvant portal infusion chemotherapy in colorectal cancer.
    Metzger U
    Recent Results Cancer Res; 1988; 110():95-100. PubMed ID: 3043601
    [No Abstract]   [Full Text] [Related]  

  • 9. [Intra-arterial chemotherapy of colorectal liver metastases with 5-fluorouracil (5-FU) and mitomycin C (MMC)].
    Weder W; Roethlin M; Metzger U; Largiadèr F
    Helv Chir Acta; 1987 Dec; 54(4):383-6. PubMed ID: 3128495
    [No Abstract]   [Full Text] [Related]  

  • 10. Treatment of advanced gastrointestinal cancer with 5-fluorouracil and mitomycin C.
    Krauss S; Sonoda T; Solomon A
    Cancer; 1979 May; 43(5):1598-603. PubMed ID: 445355
    [No Abstract]   [Full Text] [Related]  

  • 11. Combination of constant-infusion 5-fluorouracil, methyl-CCNU, mitomycin C, and vincristine in advanced colorectal carcinoma.
    Greco FA; Richardson RL; Shulman SF; Oldham RK
    Cancer Treat Rep; 1978 Sep; 62(9):1407-8. PubMed ID: 688289
    [No Abstract]   [Full Text] [Related]  

  • 12. Intrahepatic artery 5-fluorouracil and mitomycin-C in previously untreated patients with hepatic metastases from colorectal carcinoma.
    Cowan JD; Easterbrock J; Mills GM; McCracken JD
    Mil Med; 1982 Mar; 147(3):220-3. PubMed ID: 6806715
    [No Abstract]   [Full Text] [Related]  

  • 13. Chemotherapy of advanced colorectal carcinoma: fluorouracil alone vs. two drug combinations using fluorouracil, hydroxyurea, semustine, dacarbazine, razoxane, and mitomycin. A phase III trial by the Eastern Cooperative Oncology Group (EST: 1278).
    Engstrom PF; MacIntyre JM; Mittelman A; Klaassen DJ
    Am J Clin Oncol; 1984 Aug; 7(4):313-8. PubMed ID: 6377866
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mitomycin and methotrexate: negative experience in untreated colorectal carcinoma.
    Wernz JC; Kao AK; Muggia FM; Asbury RF
    Cancer Treat Rep; 1985 Feb; 69(2):223-4. PubMed ID: 3918793
    [No Abstract]   [Full Text] [Related]  

  • 15. Chemotherapy for colorectal cancer with a combination of 5-fluorouracil, mitomycin C, adriamycin, and cytosine arabinoside: a pilot study.
    Davis S; Park YK
    Cancer Treat Rep; 1978 Oct; 62(10):1557-9. PubMed ID: 709556
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemotherapy as an adjuvant to surgery for colorectal cancer. A follow-up report.
    Lawrence W; Terz JJ; Horsley JS; Brown PW; Romero C
    Arch Surg; 1978 Feb; 113(2):164-8. PubMed ID: 343748
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Postoperative adjuvant chemotherapy and radiotherapy for cancer of the large bowel and rectum.
    Smith DE; Muff NS; Shetabi H; Stutz FH; Eiesland H
    Am J Surg; 1989 May; 157(5):508-11. PubMed ID: 2496612
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adjuvant therapy for colo-rectal cancer.
    Wilson RE
    Ann Chir Gynaecol; 1983; 72(6):290-2. PubMed ID: 6364949
    [No Abstract]   [Full Text] [Related]  

  • 19. Efficacy of prolonged intermittent therapy with combined 5-fluorouracil and methyl-CCNU following resection for carcinoma of the large bowel. A Veterans Administration Surgical Oncology Group report.
    Higgins GA; Amadeo JH; McElhinney J; McCaughan JJ; Keehn RJ
    Cancer; 1984 Jan; 53(1):1-8. PubMed ID: 6360325
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase II study of mitomycin C, cyclophosphamide, and methotrexate in drug-resistant colorectal carcinoma.
    Presant CA; Ratkin G; Klahr C
    Cancer Treat Rep; 1978 Apr; 62(4):549-50. PubMed ID: 350389
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.